Connect with us
Rovi will start producing Moderna's COVID-19 vaccine in Andalusia. This investment consists of the installation of a new line to support the production phases of the...
The total shareholder return in 2020 was 19.3% in CHF and 18.1% in EUR, slightly below the performance of the underlying portfolio. In addition to Mersana...
The US company Moderna with its mRNA-based COVID-19 vaccine is currently the best-known example of how biotech companies are making progress for society. In addition to...
A recent study conducted in France by Stratégies and Leyton shows that 88% of the French people are happy that a vaccine against COVID-19 was found....
The company operates under the name of Moderna Biotech Spain and its corporate purpose is the "development, manufacture and distribution of drugs, vaccines and medicines based...
